Suchergebnisse - "Ledermann, Jonathan"

PubPharm (18)

1

Molecular determinants of clinical outcomes of pembrolizumab in recurrent ovarian cancer : Exploratory analysis of KEYNOTE-100

enthalten in: Gynecologic oncology | 2023

von Ledermann, J. | Shapira-Frommer, R. | Santin, A. | +21

2

Prognostic nomogram for progression-free survival in patients with BRCA mutations and platinum-sensitive recurrent ovarian cancer on maintenance olaparib therapy following response to chemotherapy

enthalten in: European journal of cancer (Oxford, England : 1990) | 2021

von Tjokrowidjaja, A. | Friedlander, M. | Lord, S. | +17

3

Utilizing an interim futility analysis of the OVAL study (VB-111-701/GOG 3018) for potential reduction of risk : A phase III, double blind, randomized controlled trial of ofranergene obadenovec (VB-111) and weekly paclitaxel in patients with platinum resistant ovarian cancer

enthalten in: Gynecologic oncology | 2021

von Arend, R. | Monk, B. | Herzog, T. | +11

4

Concordance between CA-125 and RECIST progression in patients with germline BRCA-mutated platinum-sensitive relapsed ovarian cancer treated in the SOLO2 trial with olaparib as maintenance therapy after response to chemotherapy

enthalten in: European journal of cancer (Oxford, England : 1990) | 2020

von Tjokrowidjaja, A. | Lee, C. | Friedlander, M. | +20

5

The effect of age on efficacy, safety and patient-centered outcomes with rucaparib : A post hoc exploratory analysis of ARIEL3, a phase 3, randomized, maintenance study in patients with recurrent ovarian carcinoma

enthalten in: Gynecologic oncology | 2020

von Colombo, N. | Oza, A. | Lorusso, D. | +23

6

Exploratory outcome analyses according to stage and/or residual disease in the ICON7 trial of carboplatin and paclitaxel with or without bevacizumab for newly diagnosed ovarian cancer

enthalten in: Gynecologic oncology | 2019

von González Martín, A. | Oza, A. | Embleton, A. | +13

7

Olaparib treatment for BRCA-mutant ovarian cancer with leptomeningeal disease

enthalten in: Gynecologic oncology reports | 2016

von Bangham, M. | Goldstein, R. | Walton, H. | +1

8

Homologous recombination deficiency and ovarian cancer

enthalten in: European journal of cancer (Oxford, England : 1990) | 2016

von Ledermann, J. | Drew, Y. | Kristeleit, R.

9

Cediranib in patients with relapsed platinum-sensitive ovarian cancer (ICON6): a randomised, double-blind, placebo-controlled phase 3 trial

enthalten in: The lancet | 2016

von Ledermann, J. | Embleton, A. | Raja, F. | +16

10

Overall survival in patients with platinum-sensitive recurrent serous ovarian cancer receiving olaparib maintenance monotherapy: an updated analysis from a randomised, placebo-controlled, double-blind, phase 2 trial

enthalten in: The lancet / Oncology | 2016

von Ledermann, J. | Harter, P. | Gourley, C. | +15